Pulmonx Corp (LUNG) — Cost of Revenue
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $23.36M | +7.2% |
| 2024 | $21.79M | +21.6% |
| 2023 | $17.92M | +29.9% |
| 2022 | $13.80M | +7.9% |
| 2021 | $12.79M | +10.9% |
| 2020 | $11.53M | +13.3% |
| 2019 | $10.18M | +31.9% |
| 2018 | $7.72M | — |
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $23.36M | +7.2% |
| 2024 | $21.79M | +21.6% |
| 2023 | $17.92M | +29.9% |
| 2022 | $13.80M | +7.9% |
| 2021 | $12.79M | +10.9% |
| 2020 | $11.53M | +13.3% |
| 2019 | $10.18M | +31.9% |
| 2018 | $7.72M | — |